🇺🇸 FDA
Patent

US 9725492

Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells

granted A61PA61P35/00A61P37/02

Quick answer

US patent 9725492 (Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61P, A61P35/00, A61P37/02